Bioventix (LON:BVXP) Releases Earnings Results

Bioventix (LON:BVXP) announced its quarterly earnings data on Monday. The biotechnology company reported GBX 145.74 EPS for the quarter, Digital Look Earnings reports. The company had revenue of GBX 1,297 million for the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%.

Bioventix Stock Up 3.8%

LON:BVXP opened at GBX 2,050 on Tuesday. The company’s 50 day moving average price is GBX 1,694.82 and its 200-day moving average price is GBX 1,656.41. Bioventix has a 52 week low of GBX 1,300 and a 52 week high of GBX 2,255. The stock has a market cap of £107.11 million, a price-to-earnings ratio of 14.59 and a beta of 0.54.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.